4C predictions anyone?, page-137

This 4c is important as it represents the litmus test for code red.

If the code red projections are realised then total revenue should be approx $7m (including tax refund) and there should be an operating loss of $2m. While cc revenue with probably grow at same rate, there may be a substantial jump in infusion sales (from new contract). If code red projections hold SP will jump.

Remember vascucel was not included in code red projections and this will be the first quarter of sales so doubt it will be significant.

So far I have been impressed with Wayne Paterson. I believe he inherited a mess. This is the first quarter where he will hold 100% responsibility for results. Will be watching very carefully. This qrt will let us know how Admedus is going on the path to profitability with Wayne steering the ship.